These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3040185)

  • 1. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens.
    Vezina P; Kalivas PW; Stewart J
    Brain Res; 1987 Aug; 417(1):51-8. PubMed ID: 3040185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat.
    Mucha RF; Iversen SD
    Brain Res; 1986 Nov; 397(2):214-24. PubMed ID: 3026557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
    Latimer LG; Duffy P; Kalivas PW
    J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area.
    Bontempi B; Sharp FR
    J Neurosci; 1997 Nov; 17(21):8596-612. PubMed ID: 9334431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects.
    Vezina P; Stewart J
    Brain Res; 1990 May; 516(1):99-106. PubMed ID: 2364286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.
    Phillips GD; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):345-59. PubMed ID: 7838928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Toxophilic effects of morphinomimetic substances. Dopamine/enkephalin interactions in the ventral tegmental area and in the nucleus accumbens].
    Stinus L; Cesselin F; Deminière JM; Bourgouin S; Hamon M; Le Moal M
    Encephale; 1989; 15 Spec No():95-104. PubMed ID: 2545434
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons.
    Kalivas PW; Duffy P
    J Pharmacol Exp Ther; 1987 Apr; 241(1):204-12. PubMed ID: 3572784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area.
    Klitenick MA; Wirtshafter D
    J Pharmacol Exp Ther; 1995 Apr; 273(1):327-36. PubMed ID: 7714785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lesion of dopamine mesolimbic neurons blocks behavioral effects induced by the endogenous enkephalins but not by a mu-opioid receptor agonist.
    Calenco-Choukroun G; Daugé V; Gacel G; Roques BP
    Eur J Pharmacol; 1991 Dec; 209(3):267-71. PubMed ID: 1665799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kelatorphan, a potent enkephalinases inhibitor, and opioid receptor agonists DAGO and DTLET, differentially modulate self-stimulation behaviour depending on the site of administration.
    de Witte P; Heidbreder C; Roques BP
    Neuropharmacology; 1989 Jul; 28(7):667-76. PubMed ID: 2761678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.
    Daugé V; Rossignol P; Roques BP
    Psychopharmacology (Berl); 1989; 99(2):168-75. PubMed ID: 2572028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose effect of ethanol on locomotor activity induced by activation of the mesolimbic system.
    Milton GV; Randall PK; Erickson CK
    Alcohol Clin Exp Res; 1995 Jun; 19(3):768-76. PubMed ID: 7573807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment.
    Noble F; Cox BM
    Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of enkephalinergic and GABAergic mediated locomotion in the nucleus accumbens by muscimol in the ventral pallidum.
    Austin MC; Kalivas PW
    Jpn J Pharmacol; 1989 Aug; 50(4):487-90. PubMed ID: 2779013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation.
    Churchill L; Kalivas PW
    Synapse; 1992 May; 11(1):47-57. PubMed ID: 1318584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site of rewarding action of morphine in the mesolimbic system determined by intracranial electrical self-stimulation.
    van Wolfswinkel L; van Ree JM
    Brain Res; 1985 Dec; 358(1-2):349-53. PubMed ID: 4075126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrochemical evidence of increased dopamine transmission in prefrontal cortex and nucleus accumbens elicited by ventral tegmental mu-opioid receptor activation in freely behaving rats.
    Noel MB; Gratton A
    Synapse; 1995 Oct; 21(2):110-22. PubMed ID: 8584972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity.
    Churchill L; Klitenick MA; Kalivas PW
    J Neurosci; 1998 Oct; 18(19):8074-85. PubMed ID: 9742174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.